Development of a method for the determination of caffeine anhydrate in various designed intact tablets [correction of tables] by near-infrared spectroscopy: a comparison between reflectance and transmittance technique.
Using near-infrared (NIR) spectroscopy, an assay method which is not affected by such elements of tablet design as thickness, shape, embossing and scored line was developed. Tablets containing caffeine anhydrate were prepared by direct compression at various compression force levels using different shaped punches. NIR spectra were obtained from these intact tablets using the reflectance and transmittance techniques. A reference assay was performed by high-performance liquid chromatography (HPLC). Calibration models were generated by the partial least-squares (PLS) regression. Changes in the tablet thickness, shape, embossing and scored line caused NIR spectral changes in different ways, depending on the technique used. As a result, noticeable errors in drug content prediction occurred using calibration models generated according to the conventional method. On the other hand, when the various tablet design elements which caused the NIR spectral changes were included in the model, the prediction of the drug content in the tablets was scarcely affected by those elements when using either of the techniques. A comparison of these techniques resulted in higher predictability under the tablet design variations using the transmittance technique with preferable linearity and accuracy. This is probably attributed to the transmittance spectra which sensitively reflect the differences in tablet thickness or shape as a result of obtaining information inside the tablets.
Ito
Masatomo
M
Formulation Technology Research Laboratories, Daiichi-Sankyo Co. Ltd., 1-12-1 Shinomiya, Hiratsuka, Kanagawa 254-0014, Japan. ito.masatomo.id@daiichisankyo.co.jp
Suzuki
Tatsuya
T
Yada
Shuichi
S
Kusai
Akira
A
Nakagami
Hiroaki
H
Yonemochi
Etsuo
E
Terada
Katsuhide
K
D001681:Biological Assay; D002110:Caffeine / Q000032:analysis*; D002138:Calibration; D000697:Central Nervous System Stimulants / Q000032:analysis*; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D002851:Chromatography, High Pressure Liquid; D019245:Compressive Strength; D004304:Dosage Forms; D016018:Least-Squares Analysis; D008956:Models, Chemical; D004364:Pharmaceutical Preparations / Q000032:analysis*; D012044:Regression Analysis; D019265:Spectroscopy, Near-Infrared / Q000379:methods*; D013607:Tablets / Q000737:chemistry*; D013678:Technology, Pharmaceutical / Q000379:methods
D000697:Central Nervous System Stimulants; D004304:Dosage Forms; D004364:Pharmaceutical Preparations; D013607:Tablets; D002110:Caffeine